Genaera Receives Non-Compliance Notice F... ( PLYMOUTH MEETING Pa. Oct. 21 /- G...)

Genaera Receives Non-Compliance Notice From NASDAQ

Date:10/21/2008

PLYMOUTH MEETING, Pa., Oct. 21 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR) today announced that it has received notification from NASDAQ that the bid price of the Company's common stock has closed below the minimum $1.00 per share requirement under NASDAQ Marketplace Rule 4310(c)(4) for the last 30 consecutive trading days.

NASDAQ also notified the Company that as of October 16, 2008 it has suspended for a three-month period the enforcement of the rules requiring a minimum $1 closing bid price or a minimum market value of publicly held shares. NASDAQ has said that it will not take any action to delist any security for these concerns during the suspension. NASDAQ has stated that, given the current extraordinary market conditions, this suspension will remain in effect through Friday, January 16, 2009 and will be reinstated on Monday, January 19, 2009.

As a result of this suspension, the Company now has until July 20, 2009 to regain compliance with the minimum bid rule. If at any time before July 20, 2009, the bid price of the Company's common stock closes at $1.00 per share or more for a minimum of 10 consecutive business days, NASDAQ will provide written notification that it has achieved compliance with the Rule.

If the Company does not regain compliance with the Rule by July 20, 2009, NASDAQ will determine whether the Company meets The Nasdaq Capital Market initial listing criteria as set forth in Marketplace Rule 4310(c), except for the bid price requirement. If it meets the initial listing criteria, NASDAQ will notify the Company that it has been granted an additional 180 calendar day compliance period.

About Genaera

Genaera Corporation is developing trodusquemine (MSI-1436), for type
'/>"/>

SOURCE Genaera Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
2. Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation
3. Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph
4. Xmark Comments on Genaera Cost-Saving Plan
5. Genaera Corporations 2008 Annual Stockholder Meeting Results
6. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
7. DaVita Receives Civil Complaint
8. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
9. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
10. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
11. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers

Post Your Comments:

(Date:12/1/2009).... 1 The Kerlan Jobe Ort...ngeles, has agreed to pay the United States $3 mil...l kickbacks from HealthSouth Corporation, the Just...tlement resolves allegations that HealthSouth paid...ion grants, donations to the Kerlan Jobe Foundatio...

(Date:12/1/2009)...ec. 1 A decision issued today by a... Board (NLRB) has put at risk the guaranteed raise...manente RNs, social workers, and professionals in ...rs to achieve standards at Kaiser that give us sec...e our patients need," said Jeanette Cryer, License...

(Date:12/1/2009)...gests that criteria based on computed tomography (...iver metastases after chemotherapy with the drug b...ll survival, according to a study in the December ...b to cytotoxic (toxic to cells) chemotherapy is as...tage IV colorectal cancer and higher pathologic re...

(Date:12/1/2009)...NS, Dec. 1 The American...High School Student Symposium at the New Orleans M... The symposium, which encourages an interest in he...earch, is held in conjunction with the Society,s 5...the opportunity to explore research on sickle cell...

(Date:12/1/2009)...Dec. 1 The government of Mexico Ci...ter for biomedical and nanomedical research, calle...search and development will be integrated with the... Spanish speaking university in the world. The re... 2010, has been designed by the internationally-ac...

Breaking Medicine News(10 mins):Health News:Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations 2 Health News:Labor Board Decision Puts Kaiser Workers' Pay, Healthcare, Pensions in Jeopardy 2 Health News:Criteria based on CT imaging after chemotherapy may help predict survival 2 Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2 Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3 Health News:Mexico City to Build World-Class Hub for Medical Research 2

[0] Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations [0] Labor Board Decision Puts Kaiser Workers' Pay, Healthcare, Pensions in Jeopardy [0] Criteria based on CT imaging after chemotherapy may help predict survival [1] ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum [1] Mexico City to Build World-Class Hub for Medical Research

... EPS Growth of 53.3 Percent) - , , - Confirms Dou...reased 2009 Dividend by 11 Percent - , , ABBOTT... announced financial results for the first quarter... above the mid-point of Abbott,s previous first-qu...

...upply today announced that after only 20 months it...will now officially be known as Simplex Healthcare... April 15, 2009 -- Simplex Diabetic Supply today a...ur company has accomplished our initial mission of...

...BRA and Medicare considerations; people with disab...althcare coverage , Belle...rovisions in the 2009 American Recovery and Reinve...ing to Allsup , a leading provider of Social Secu...

...to represent executive board and individual union ...on on recognition of collective bargaining rights ...April 15, 2009 -- Taubman Kimelman & Soroka ,...by Local 2222 of the American Federation of Govern...

... issue of the Journal of Clinical Sleep Medicine ...ing sleep disorders in adults with a traumatic bra...ay result in the objective resolution of the sleep...sleep apnea (OSA), three months of treatment with ...

...arasites in east and west Africa carry different r...tiveness of sulfadoxine as an antimalarial drug ma...ations for the manner in which malaria control cam...ffective than working in isolation in each country...

Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009 Simplex Diabetic Supply Changes Its Name to Simplex Healthcare Jobless Should Evaluate COBRA, Medicare in Light of 2009 Recovery Act Taubman Kimelman & Soroka Retained by AFGE Local 2222 to Advise in Organizing of New York and New Jersey Transportation Security Officers Treating sleep disorders in people with traumatic brain injury may not eliminate symptoms Discovery of variations in resistance to sulfadoxine across Africa

(Date:12/1/2009)...Dec. 1 Reportlinker.com announces ...its catalogue: ,, Direct to Consumer (DTC) Adv...arket Outlook, Regulatory Landscape and Case Studi...rect-to-Consumer-DTC-Advertising-in-Pharmaceutical...andscape-and-Case-Studies.html ,, Summary ,...

(Date:12/1/2009)..., Dec. 1 CeloNova BioSciences, Inc...medical devices and of specialty implants, today a...r, Thomas A. Gordy, will give an opening address f...diovascular Interventions Conference in Tel Aviv, ...rest behind and focus the rich intellectual resour...

(Date:12/1/2009)... Tenn., Dec. 1 Cumberlan...today that an independently conducted study of Ace...s N-acetylcysteine, as a cost-saving treatment for...2, Number 4 of the peer-reviewed Journal of Medic...y concludes that Acetadote is a less costly treatm...

Breaking Medicine Technology:Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 2 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 3 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 4 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 5 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 6 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 7 Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies 8 CeloNova BioSciences CEO Urges More Heart, More Passion, More Honesty, and All Urgency in Developing Medical Devices 2 Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 2 Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 3 Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 4 Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 5 Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 6 Super sleepers could help super sizers 21 9034 1 Super sleepers could help super sizers 21 9034 2 Reading the brain without poking it 9033 1 Reading the brain without poking it 9033 2 Reading the brain without poking it 9033 3 Reading the brain without poking it 9033 4 Reading the brain without poking it 9033 5 GP bodies support guidelines for use of patient records in medical research 50226 1 GP bodies support guidelines for use of patient records in medical research 50226 2

[0] Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies [0] CeloNova BioSciences CEO Urges More Heart, More Passion, More Honesty, and All Urgency in Developing Medical Devices [0] Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems

...v. 7 Data from an investigational,open-label, ran...f,PROCRIT(R) (Epoetin alfa) in treating anemia in ...(CKD) were presented today at the American Society...sing groups, including the FDA-approved,three-time...d,once-every-two-weeks (Q2W) investigational regim...

...ov. 7 Spherix Incorporated,(Nasdaq: SPEX ) repor...cal,trial of its potential type 2 diabetes drug, N...India are to provide more than 300 patients spread...ow that enrollment efforts,are underway in India, ...d,on schedule as reported during the May 2008 Annu...

Other Medicine Technology:Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 2 Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 3 Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 4 Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 5 Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 6 Patient Recruitment Begins in India for Phase 3 Diabetes Trial 2

Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting Patient Recruitment Begins in India for Phase 3 Diabetes Trial

Innova 3100 Water Bath Shaker

55D Double Platform Shaker 11 x 14

Innova 5000 Muti-Tier Shaker

...up to 16 of AutoGen's tube units to prepare 96 sam...te for bacterial cultures and enzyme reactions, su... simplify your DNA extraction process by preparing...lacing our 6-hole tube units directly onto one of ...

Medicine Products:

Innova 3100 Water Bath Shaker 55D Double Platform Shaker 11 x 14 Innova 5000 Muti-Tier Shaker AutoIncubator 96

Genaera Receives Non-Compliance Notice F...( PLYMOUTH MEETING Pa. Oct. 21 /- G...),Health